4
Changes in Ownership
Amneal Pharmaceuticals, Inc. Filed Acc 0001628280-24-049297
Director sold 17,058 shares at $8.38 ($142,946)
- Director acquired 28,506 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kiely John Director | 2024-11-22 | Option exercise | +28,506 | $4.76 | $135,689 | 284,233 | D |
| Kiely John Director | 2024-11-22 | Sale | −17,058 | $8.38 | $142,946 | 267,175 | D |
| Derivatives | |||||||
| Kiely John Director | 2024-11-22 | Option exercise · Stock Option | −28,506 | 0 | D | ||
| Open-market sales · 17,058 sh · avg $8.38 · $142,946 | |||||||
Loading xslF345X05/wk-form4_1732657281.xml…